Cargando…
Moderate expression of TRF2 in the hematopoietic system increases development of large cell blastic T-cell lymphomas
The telomeric repeat binding factor 2 (TRF2) plays a central role in the protection of chromosome ends by inhibiting telomeres from initiating a DNA damage cascade. TRF2 overexpression has been suggested to induce tumor development in the mouse, and TRF2 levels have been found increased in human tum...
Autores principales: | Begemann, Sebastian, Galimi, Francesco, Karlseder, Jan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2772070/ https://www.ncbi.nlm.nih.gov/pubmed/20046894 |
Ejemplares similares
-
CD4+CD56+ Lineage Negative Hematopoietic Neoplasm : So Called Blastic NK Cell Lymphoma
por: Kim, Yoonjung, et al.
Publicado: (2005) -
Blastic natural killer cell lymphoma/leukaemia in a
cat
por: Hirabayashi, Miyuki, et al.
Publicado: (2019) -
Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma
por: LeBlanc, Francis R., et al.
Publicado: (2022) -
Allogeneic Hematopoietic Cell Transplantation for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
por: Bashir, Qaiser, et al.
Publicado: (2022) -
Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis
por: Murthy, Hemant S., et al.
Publicado: (2023)